NFKB1 and Hepatic steatosis: Consistently, TRIM8 knockdown attenuates liver steatosis by reducing the secretion of pro-inflammatory modulators, such as IL-6, IL-1β, TNF-α and CXCL-2 with consequent inactivation of the NF-κB pathway [66,67].